Hodgkin Disease
📧 Sign up to get email alerts when something new happens for Hodgkin Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS withdrawal · 2015-03-24Clinical Trial Update: This is a Multi-center, Single Arm, Open Label Study Intended to Provide Expanded Access to Plerixafor for Patients With Non-Hodgkin's Lymphoma (NHL), Hodgkin's Disease (HD) or Multiple Myeloma (MM) Who Are to Receive Treatment With an Autologous Peripheral Stem Cell Transplant.
This entry describes an expanded-access, multi-center, single-arm, open-label study of plerixafor for patients with non-Hodgkin's lymphoma, …